US Patent Issued to ST. JOHN'S UNIVERSITY on Aug. 25 for "Method for measuring COPD biomarkers" (New York Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,898, issued on Aug. 25, was assigned to ST. JOHN'S UNIVERSITY (Queens, N.Y.).

"Method for measuring COPD biomarkers" was invented by Michael Fagiola (Queens, N.Y.) and Jerome Cantor (Queens, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention pertains to the use of a specific biomarker of elastin degradation (desmosine) that measures the extent and progression of chronic obstructive pulmonary disease (COPD). In addition to potentially serving as a screening procedure for COPD, it provides a real-time measure of COPD drug efficacy and may therefore supersede the use of less sensitive tests such as pulmonary function studies and computed...